As per the research report, the size of the Asia Pacific Contrast Injector Market is valued at USD 83.86 million in 2020 and is projected to be growing at a CAGR of 11.5%, to touch USD 144.51 million by 2025 during the forecast period 2020-2025.
A medical contrast medium is a substance used to enhance the contrast of fluids or structures within the body, for medical imaging. The delivery of these media is most efficient and effective by the use of a medical device known as a power injector or contrast injector.
The functioning of a contrast injector involves a blend of overlapping processes from the areas of pressure, thermal, electricity, rheology, viscosity, syringe, catheter and computer technologies. Contrast Injectors have varied applications in the fields of computed tomography, interventional radiology and magnetic resonance imaging (MRI) The growth of the Asia-Pacific Contrast Injector Market is majorly driven by the increasing presence of international players in the region to tap the humongous market potential. Market growth is further augmented by the increasing approvals for various contrast agents in the countries of the Asia-Pacific, and the environment of developing economies such as India and China is favourable for market growth, which has led to the increased presence of private and public diagnostic centres.
This research report segmented and sub-segmented into the following categories:
Asia-Pacific is a fast-developing Contrast Injector Market which is expected to grow at the highest CAGR, due to the availability of massive untapped markets and enormous population base. Factors such as growing contrast media approvals and growing diagnostic infrastructure in countries such as India and China are expected to lead the growth of the market in this region. Further, rapid expansion by leading market players to access the untapped markets in the region is expected to boost the market growth in the region.
The Top companies leading in the APAC Contrast Injector Market profiled in the report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Injector Systems
5.1.2.1 CT Injector Systems
5.1.2.2 MRI Injector Systems
5.1.2.3 Angiography Injector Systems
5.1.3 Consumables
5.1.3.1 Injector Heads
5.1.3.2 Syringes
5.1.3.3 Tubing
5.1.3.4 Other Consumables
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Radiology
5.2.3 Interventional Cardiology
5.2.4 Interventional Radiology
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Bracco Imaging S.p.A.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer HealthCare
8.3 Guerbet Group
8.4 Medtron AG
8.5 ulrich GmbH & Co. KG
8.6 GE Healthcare
8.7 AngioDynamics
8.8 Nemoto Kyorindo Co.
8.9 Sino Medical- Device Technology
8.10 VIVID IMAGING
8.11 Apollo RT Co.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Feb 2020
